Jason Shand Robins
CIK: 0002104600
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OCUL
OCULAR THERAPEUTIX, INC
Officer
Discretionary Trading P&L
Holdings
About Robins Jason Shand
Robins Jason Shand (SEC CIK 0002104600) files insider reports with the SEC as Chief Financial Officer of OCULAR THERAPEUTIX, INC (OCUL).
Signal8 holds 3 ownership filings by Robins Jason Shand (1 Form 3, 2 Form 4), filed between Jan 22, 2026 and Jun 12, 2026. Those filings report 2 transactions, from Jan 20, 2026 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Robins Jason Shand's filings is in BEDFORD, MA.
Recent filings by Robins Jason Shand
Other insiders filing for OCULAR THERAPEUTIX, INC (OCUL)
- Anderman Todd, Chief Legal Officer
- Kaiser Peter, Chief Development Officer
- Heier Jeffrey S., Chief Scientific Officer
- Notman Donald, Chief Operating Officer
- Nayak Sanjay, Chief Strategy Officer
- Dugel Pravin